PLAU, plasminogen activator, urokinase, 5328

N. diseases: 439; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2937358
Disease: Cerebral Hemorrhage
Cerebral Hemorrhage
0.300 Biomarker phenotype CTD_human Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. 17702958 2007
CUI: C2937358
Disease: Cerebral Hemorrhage
Cerebral Hemorrhage
0.300 Biomarker phenotype CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004
CUI: C2937358
Disease: Cerebral Hemorrhage
Cerebral Hemorrhage
0.300 Biomarker phenotype CTD_human Local intra-arterial thrombolysis in acute ischemic stroke. 9731615 1998
CUI: C2937358
Disease: Cerebral Hemorrhage
Cerebral Hemorrhage
0.300 Biomarker phenotype CTD_human Intracerebral hemorrhage complicating urokinase infusion into an occluded aortocoronary bypass graft. 8025938 1994
CUI: C2937358
Disease: Cerebral Hemorrhage
Cerebral Hemorrhage
0.300 Biomarker phenotype CTD_human Intracranial bleeding associated with urokinase therapy for acute ischemic hemispheral stroke. 1265806 1976